| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC2754 | Isomazole | Potent inotropic agent, inhibiting both PDE3 and PDE4 |
|
| DCC2755 | Isomyristicin | Natural essential oil, showing activity against T. muris |
|
| DCC2756 | Isopedopeptin B | Natural antibacterial agent with cytotoxicity and hemolytic properties against a larger panel of Gram-negative bacteria |
|
| DCC2757 | Iso-ppads | P2X-purinoceptor antagonist |
|
| DCC2758 | Isowighteone | Natural genistein derivetive with antibacterial and antifungal activities |
|
| DCC2759 | Isoxaben | Inhibitor of the cellulose biosynthesis, inhibiting anisotropic cell expansion resulting in a severely swollen and stunted growth phenotype |
|
| DCC2760 | Isox-inact | Biological Active Reagents |
|
| DCC2761 | Isph Inhibitor 23.20-tpp | Novel prodrug of potent IspH inhibitor, killing clinical isolates of several multidrug-resistant bacteria, including those from the genera Acinetobacter, Pseudomonas, Klebsiella, Enterobacter, Vibrio, Shigella, Salmonella, Yersinia, Mycobacterium and Baci |
|
| DCC2762 | Isp-vt | Novel inhibitor of COX and neutrophil migration |
|
| DCC2763 | Isq-1 Hydrochloride | Distinct IKur blocker |
|
| DCC2764 | Ist-622 | Unique topoisomerase inhibitor, showing significant growth-inhibitory effects against large-cell lung cancer (Lu-116) and gastric adenocarcinoma (St-4) |
|
| DCC2765 | Isvy130 | Novel Potent and Selective A3 Antagonist |
|
| DCC2766 | Ite-atra | Novel degrader of CRABP proteins |
|
| DCC2767 | Ite-conhch3 | Novel highly potent (EC 50 = 1.6 nM) aryl hydrocarbon receptor (AhR) agonist with high affinity (K i = 88 nM) |
|
| DCC2768 | Itf3756 | Novel Potent and Selective Histone Deacetylase 6 (HDAC6) Inhibitor, showing a remarkably low toxicity both in vitro and in vivo and increasing the function of regulatory T cells (Tregs) at well-tolerated concentrations |
|
| DCC2769 | Itf3985 | Novel selective HDAC6 inhibitor |
|
| DCC2770 | ith12246 | Novel PP2A ligand, protecting against memory impairment and focal cerebral ischemia in mice |
|
| DCC2771 | Ith12505 | Novel neuroprotective agent |
|
| DCC2772 | Ith15004 | Novel, potent, selective, and BBB-permeable P2X7 antagonist |
|
| DCC2773 | Itx-4520 | Novel highly potent, orally bioavailable hepatitis C virus (HCV) entry inhibitor |
|
| DCC2774 | Ityr-dbrmd | First-in-class iodothyronine deiodinase type 3 (DIO3) inhibitor, demonstratig attenuated cell counts, induction in apoptosis, and a reduction in cell proliferation in DIO3-positive HGSOC cells (OVCAR3 and KURAMOCHI) |
|
| DCC2775 | Ivabradine | Selective inhibitor of the funny channel pacemaker current (If) in the sinoatrial node in a dose-dependent fashion, resulting in a lower heart rate and thus more blood to flow to the myocardium |
|
| DCC2776 | Ivde77 | The first Ang IV-analogue being able to abolish IRAP-availability completely at the cell surface in vitro |
|
| DCC2777 | Ivq Hydrochloride | Prodrug of QVO, being quickly converted to QVO in mice and rats following administration, ameliorating hyperglycemia, and suppressing hepatic gluconeogenesis and activating AMPK signaling pathway in the liver tissues |
|
| DCC2778 | Iwp-051 | Novel, orally available soluble guanylate cyclase (sGC) stimulator with once-daily dosing potential for the treatment of cardiovascular diseases |
|
| DCC2779 | Iwp2g9 | Novel WNT inhibitor, suppressing cytoplasmic and nuclear biochemical markers of WNT signaling in cultured cells, inhibiting recombinant TNKS activity, or WNT fatty acylation |
|
| DCC2780 | Iwr107 | Novel WNT inhibitor, suppressing cytoplasmic and nuclear biochemical markers of WNT signaling in cultured cells, inhibiting recombinant TNKS activity, or WNT fatty acylation |
|
| DCC2781 | Iy-iy-das | Novel potent noncleavable proteolysis targeting chimeric (PROTAC) for TrkC degradation in metastatic breast cancer cells |
|
| DCC2782 | Iy-iy-ss-das | Novel potent and cleavable proteolysis targeting chimeric (PROTAC) for TrkC degradation in metastatic breast cancer cells |
|
| DCC2783 | J-2156 Tfa Salt | Potent and selective agonist of human somatostatin receptor 4 (sst4), reducing mechanosensitivity of peripheral nerve afferents and spinal neurons in an inflammatory pain model |
|
